VOLT-02

From Wikipedia, the free encyclopedia
VOLT-02
Clinical data
Other namesProgesterone conjugate
Drug classProgestogen; Neurosteroid

VOLT-02 is a water-soluble conjugate of progesterone and a neurosteroid which is under development by Levolta Pharmaceuticals (formerly Voltarra Pharmaceuticals) for the treatment of traumatic brain injury, gynecological disorders, and menstrual disorders.[1] As of March 2017, it is in phase II clinical trials for these indications.[1] The chemical structure of VOLT-02 does not appear to have been released yet.[1]

See also[]

  • List of neurosteroids § Inhibitory > Synthetic > Pregnanes
  • List of progestogen esters § Oximes of progesterone derivatives
  • List of investigational sex-hormonal agents § Progestogenics

References[]

  1. ^ a b c "Progesterone conjugate - Levolta Pharmaceuticals - AdisInsight". adisinsight.springer.com.

External links[]



Retrieved from ""